Official UK procurement notice
RSV Pharmacy Expansion (London)
Authority: NHS England (Central government)
What is being bought4 lots · detail below
Published requirement descriptionNHS England (London Region) invites suitable and qualified Pharmacies to submit their interest and completed Invitation to Tender (ITT) submissions for the delivery of RSV Expansion Services.
Outline
Successful Suppliers will be commissioned via a CP ES which will be of the type referred to in direction 14 of the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 as amended. Details of the Enhanced Service requirements will be set out in an ES specification which cannot be altered locally. Successful Suppliers will provide the Services in accordance with the terms of the CP ES and in full compliance with their Terms of Service or Local Pharmaceutical Services contract terms, as applicable.
This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt the provisions of the Public Contract Regulations 2015 does not apply to this award.
The Procurement is being managed by the NHS London Commercial Hub (NHS LCH) hosted by NEL ICB, on behalf of the Authority, in connection with a competitive Invitation to Tender (ITT) exercise that is being conducted via a competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023.
CPV: Pharmacy services
Lots and requirements (4)Procurement structure
4 lots · all with a published value (£38 together)Lot #1North West LondonPublished value£10
The purpose of this procurement is to engage provider's offering a suitable pharmaceutical Service to support RSV expansion within the London region.
Further detail can be found within the ITT documents.
The contract term will be 18 months with the option to extend for a further 2 years at the sole discretion of the Authority.
The contract will start in September 2025 and end 31/03/2027 with an optional extension for a further two years
The lifetime value of the contract is undetermined due to its service based requirement.
Lot #2North Central LondonPublished value£10
The purpose of this procurement is to engage provider's offering a suitable pharmaceutical Service to support RSV expansion within the London region.
Further detail can be found within the ITT documents.
The contract term will be 18 months with the option to extend for a further 2 years at the sole discretion of the Authority.
The contract will start in September 2025 and end 31/03/2027 with an optional extension for a further two years
The lifetime value of the contract is undetermined due to its service based requirement.
Lot #3North East LondonPublished value£10
The purpose of this procurement is to engage provider's offering a suitable pharmaceutical Service to support RSV expansion within the London region.
Further detail can be found within the ITT documents.
The contract term will be 18 months with the option to extend for a further 2 years at the sole discretion of the Authority.
The contract will start in September 2025 and end 31/03/2027 with an optional extension for a further two years
The lifetime value of the contract is undetermined due to its service based requirement.
Lot #4South LondonPublished value£10
The purpose of this procurement is to engage provider's offering a suitable pharmaceutical Service to support RSV expansion within the London region.
Further detail can be found within the ITT documents.
The contract term will be 18 months with the option to extend for a further 2 years at the sole discretion of the Authority.
The contract will start in September 2025 and end 31/03/2027 with an optional extension for a further two years
The lifetime value of the contract is undetermined due to its service based requirement.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- Suitability
Pharmacy premise situated within the sub-lot geographical radius.
- Premise situated on the Pharmaceutical list of the relevant health and wellbeing board where the service is being delivered.
- Premise registered on the GPhC
- Premise meets the particulars of NHS Schedule 4
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Closed
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 10 Jun 2025, 11:14 BST
- Last source update
- 10 Jun 2025, 11:14 BST
- Award evaluation window
- 30 Jun 2025 – …
- Authority reference
PRJ2152- FTS notice number
2025/S 000-031192- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0545efFind a Tender
How it was run
Official notice- Submission deadline
- 27 Jun 2025, 12:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bids opened
- 30 Jun 2025, 17:00 BST
Timeline
10 Jun 2025 → 19 Sept 2025 · 4 dates- Notice published10 Jun 2025, 11:14 BST
- Submission deadline27 Jun 2025, 12:00 BST
- Bids opened30 Jun 2025, 17:00 BST
- Contract starts19 Sept 2025, 00:00 BST
Contracting authority & participating public bodies
Dispute resolution & review bodies
- NHS EnglandReview body
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.